Aumovio (AMV0) Q3 2025 earnings summary

Executive summary

• Achieved first standalone quarter as a listed company after a successful spin-off and Prime Standard listing in Frankfurt, progressing toward 2025 targets despite a challenging automotive market.

• Transformation strategy focused on operational efficiency, cost discipline, and portfolio optimization is delivering tangible results, with a clear three-pillar strategy: Lead, Transform, Deliver.

• Strong execution on cost control and operational efficiency drove significant adjusted EBIT growth of 146.4% to €409 million for the first nine months, despite a 4.2% decline in adjusted sales year-over-year.

• Net income improved to -€223 million for the nine months, with Q3 net income at -€19 million.

Financial highlights

• Adjusted sales for the first nine months were €14.1 billion, down 4.2% year-over-year, mainly due to FX effects, portfolio adjustments, and a soft European market.

• Adjusted EBIT rose to €409 million (2.9% margin), up nearly 150% year-over-year, driven by cost savings and improved gross margin.

• Adjusted free cash flow before spinoff and restructuring costs was €190 million; after these one-offs, free cash flow was -€150 million.

• CapEx for the period was €491 million (3.5% of sales), reflecting disciplined investment.

• Net liquidity stood at €1,131 million as of September 30, 2025, with total liquidity of nearly €4 billion.

Outlook and guidance

• Sales guidance for 2025 narrowed to €18–19 billion (from €18–20 billion), with adjusted EBIT margin expected at the upper end of the 2.5%–4% range.

• Positive adjusted free cash flow targeted by year-end.

• No dividend expected for 2025; capital allocation decisions to be revisited post-restructuring.

• R&D net to sales ratio targeted to reach single digits by 2027.

• CapEx expected to remain below 5% of sales in the long run.